US Edition
LEO Pharma's Anzupgo Cream Receives FDA Approval
Summary by Pharmaceutical Business Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
LEO Pharma's Anzupgo cream receives FDA approval
This steroid-free, topical pan-Janus kinase (JAK) inhibitor is a new option for patients who have not responded adequately to other treatments or cannot use topical corticosteroids. Anzupgo works The post LEO Pharma’s Anzupgo cream receives FDA approval for chronic hand eczema appeared first on Pharmaceutical Business review.
Leo Pharma receives important US approvalLeo Pharma has received approval for its cream Anzupgo for the treatment of moderate to severe chronic hand eczema in adults from the US health authorities, the Food and Drug
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
